IDH2 and neoplasm: To evaluate the clinical features and gene mutation characteristics among the four immune clusters, age, gender, tumor grade, IDH1 (R132) status, IDH2 R172 status, PTEN status, EGFR status, ATRX status ,and TP53 status in TCGA dataset were counted (Table 1; Figure 5).